{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:38:02Z","timestamp":1785332282185,"version":"3.55.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1975,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP19ek0109370h0002"],"award-info":[{"award-number":["JP19ek0109370h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ek0109370h0002"],"award-info":[{"award-number":["JP19ek0109370h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Bleeding is a serious complication in patients with continuous-flow left ventricular assist device (CF-LVAD). Acquired von Willebrand syndrome (AVWS; type 2A) develops because of high shear stress inside the pumps and is a cause of bleeding complication. Although von Willebrand factor (vWF) multimer analysis is useful for diagnosing AVWS, it is only performed in specialized research institutes. A novel microchip flow chamber system, the total thrombus-formation analysis system (T-TAS), is a point-of-care system to evaluate the thrombus-formation process and useful for monitoring platelet thrombus-formation capacity in patients receiving antiplatelet therapy and the diagnosis and evaluation of the clinical severity of von Willebrand disease type 1. However, little is known about the association between AVWS and platelet thrombus-formation capacity evaluated by T-TAS in patients with CF-LVAD. We aimed to evaluate the utility of T-TAS for easy detection of AVWS in patients with CF-LVAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We simultaneously evaluated the vWF large multimers and T-TAS parameters in four consecutive patients with axial-type CF-LVAD and eight control patients treated with aspirin and warfarin. vWF large multimer index was defined as the proportion of large multimers in total vWF derived from a normal control plasma. T-TAS analyses different thrombus-formation processes using two microchips with different thrombogenic surfaces. PL24-AUC10 levels in the platelet (PL) chip are highly sensitive for platelet functions, while AR10-AUC30 levels in the atheroma (AR) chip allow the assessment of the overall haemostatic ability. vWF large multimer index and T-TAS parameters were decreased in all patients with CF-LVAD. The mean PL24-AUC10 level (5.4 \u00b1 2.9 vs. 219 \u00b1 67; P &amp;lt; 0.01), AR10-AUC30 level (338 \u00b1 460 vs. 1604 \u00b1 160; P &amp;lt; 0.01) and vWF large multimer index (49 \u00b1 11% vs. 112 \u00b1 27%; P &amp;lt; 0.01) were significantly lower in the patients with CF-LVAD than in control patients. One patient showed changes in T-TAS levels before and after implantation of CF-LVAD. PL24-AUC10 and AR10-AUC30 levels decreased from 438.1 to 5.0 and from 1667.9 to 1134.3, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with CF-LVAD, the platelet thrombus-formation capacity was extremely impaired because of AVWS, and T-TAS parameters could detect the presence of AVWS. T-TAS can be used for easy detection of AVWS as a point-of-care testing. Further studies with a large sample size are needed to validate our results in several LVAD models and evaluate the prognostic value of bleeding complications and thromboembolism in patients with LVAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12824","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T04:08:41Z","timestamp":1595477321000},"page":"3235-3239","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Detection of Acquired Von Willebrand Syndrome After Ventricular Assist Device by Total Thrombus-Formation Analysis System"],"prefix":"10.1093","volume":"7","author":[{"given":"Seiji","family":"Takashio","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Center for Metabolic Regulation of Healthy Aging, Kumamoto University , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita*","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Center for Metabolic Regulation of Healthy Aging, Kumamoto University , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Center for Metabolic Regulation of Healthy Aging, Kumamoto University , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Center for Metabolic Regulation of Healthy Aging, Kumamoto University , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Higo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University , Fukuoka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shiose","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kyushu University , Fukuoka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Doman","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology, Institute of Development, Aging, and Cancer, Tohoku University , Sendai ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology, Institute of Development, Aging, and Cancer, Tohoku University , Sendai ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Center for Metabolic Regulation of Healthy Aging, Kumamoto University , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Center for Metabolic Regulation of Healthy Aging, Kumamoto University , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"2026012114045336900_ehf212824-bib-0001","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"key":"2026012114045336900_ehf212824-bib-0002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5551\/jat.RV17031","article-title":"Acquired von Willebrand syndrome associated with cardiovascular diseases","volume":"26","author":"Horiuchi","year":"2019","journal-title":"J Atherosclerosis Thromb"},{"key":"2026012114045336900_ehf212824-bib-0003","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/ejcts\/ezy172","article-title":"Association between the severity of acquired von Willebrand syndrome and gastrointestinal bleeding after continuous-flow left ventricular assist device implantation","volume":"54","author":"Sakatsume","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012114045336900_ehf212824-bib-0004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mvr.2011.11.007","article-title":"A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process","volume":"83","author":"Hosokawa","year":"2012","journal-title":"Microvasc Res"},{"key":"2026012114045336900_ehf212824-bib-0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jth.13256","article-title":"Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy","volume":"14","author":"Arima","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2026012114045336900_ehf212824-bib-0006","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005263","article-title":"Total thrombus-formation analysis system predicts periprocedural bleeding events in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"6","author":"Oimatsu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026012114045336900_ehf212824-bib-0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/hae.12610","article-title":"Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system","volume":"21","author":"Ogiwara","year":"2015","journal-title":"Haemophilia"},{"key":"2026012114045336900_ehf212824-bib-0008","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.5551\/jat.30809","article-title":"Unexpectedly high prevalence of acquired von Willebrand syndrome in patients with severe aortic stenosis as evaluated with a novel large multimer index","volume":"22","author":"Tamura","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"2026012114045336900_ehf212824-bib-0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002744","article-title":"Total thrombus-formation analysis system (T-TAS) can predict periprocedural bleeding events in patients undergoing catheter ablation for atrial fibrillation","volume":"5","author":"Ito","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026012114045336900_ehf212824-bib-0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5551\/jat.49700","article-title":"Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease","volume":"27","author":"Mitsuse","year":"2020","journal-title":"J Atheroscler Thromb"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12824","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/3235\/65807042\/eschf_7_5_3235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/3235\/65807042\/eschf_7_5_3235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:05:17Z","timestamp":1769022317000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/5\/3235\/8372015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,7,23]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12824","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"2020-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}